论文部分内容阅读
我们从1990年4月至1992年6月使用体外反搏和蝮蛇抗栓酶(以下简称抗栓酶)治疗22例老年缺血性心、脑血管病,试图从改善血液流变学的角度控制疾病的发生和发展,同时设单用抗枪酶治疗20例老年缺血性心、脑血管病为对照组,我们观察治疗前后血液流变学各项指标,(1)治疗组治疗前后纤维蛋白原、血沉、血沉K值、全血粘度低切,全血还原粘度、红细胞压积、血浆粘度有显著差异。(2)治疗组与对照组相比,红细胞压积有非常显著差异、纤维蛋白原、血浆粘度、血沉K值有显著差异。体外反搏和抗栓酶治疗老年缺血性心、脑血管病降粘作用优于单用抗栓酶。
From April 1990 to June 1992, we treated 22 elderly patients with ischemic heart and cerebrovascular disease with external counterpulsation and viper antithrombotic enzyme (hereinafter referred to as antithrombin), trying to improve blood rheology Control the occurrence and development of the disease, while the use of anti-gun enzyme treatment of 20 cases of elderly ischemic heart and cerebrovascular disease as the control group, we observed various indicators of hemorheology before and after treatment, (1) treatment group before and after treatment of fiber Protein, ESR, erythrocyte sedimentation rate K value, whole blood viscosity low cut, whole blood reducing viscosity, hematocrit, plasma viscosity were significantly different. (2) Compared with the control group, the hematocrit in the treatment group was significantly different, fibrinogen, plasma viscosity, erythrocyte sedimentation rate K values were significantly different. Extracorporeal counterpulsation and antithrombotic treatment of elderly patients with ischemic heart and cerebrovascular disease than the single use of antithrombotic effect.